Activation of Stat3 signalling is shown to be correlated with the resistance of cancer cells to cisplatin‐induced apoptosis, and suppression of STAT3 by siRNAs increases the chemotherapeutic sensitivity of cisplatin‐resistant non‐small‐cell lung cancer cells 71. Here, STAT3 is linked to cancer.